BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$59.56

Market cap

$9.07B

P/E Ratio

N/A

Dividend/share

$0.2

EPS

-$0.7

Enterprise value

$10.71B

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 20
Relative Profitability: Rel. Profitability: 28

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value ...

Highlights
The quick ratio has increased by 33% YoY and by 22% from the previous quarter
BRKR's equity is up by 32% YoY but it is down by 2.7% QoQ
Bruker's debt has decreased by 25% YoY but it has increased by 9% from the previous quarter
BRKR's EPS has dropped by 192% since the previous quarter
The net income has dropped by 189% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bruker.com
Peers: TMO BIO WAT A

Key stats

What are the main financial stats of BRKR

BRKR stock price

How has the Bruker stock price performed over time
Intraday
-0.6%
1 week
3.22%
1 month
-1.44%
1 year
76.21%
YTD
26.43%
QTD
-1.03%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$3.5B
Gross profit
$1.62B
Operating income
-$30.6M
Net income
-$71.2M
Gross margin
46.4%
Net margin
-2%
The net income has dropped by 189% year-on-year
Bruker's net margin has plunged by 187% YoY
BRKR's operating margin has shrunk by 169% QoQ and by 117% YoY
BRKR's operating income has dropped by 166% since the previous quarter and by 117% year-on-year

Price vs fundamentals

How does BRKR's price correlate with its fundamentals

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
BRKR P/E details
P/E
N/A
P/B
3.78
P/S
2.59
EV/EBIT
N/A
EV/EBITDA
47.12
EV/Sales
3.06
BRKR's EPS has dropped by 192% since the previous quarter
The stock's price to book (P/B) is 44% less than its 5-year quarterly average of 6.8 but 40% more than its last 4 quarters average of 2.7
BRKR's equity is up by 32% YoY but it is down by 2.7% QoQ
The stock's price to sales (P/S) is 36% more than its last 4 quarters average of 1.9 but 22% less than its 5-year quarterly average of 3.3

Efficiency

How efficient is Bruker business performance
Bruker's return on equity has shrunk by 200% YoY and by 175% QoQ
BRKR's return on assets has dropped by 183% since the previous quarter
Bruker's return on invested capital has shrunk by 111% QoQ and by 103% YoY
BRKR's return on sales has dropped by 109% since the previous quarter and by 102% year-on-year

Dividends

What is BRKR's dividend history
Dividend details
DPS
$0.2
Dividend yield
0.34%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Bruker financials performed over time
BRKR's total assets is 66% greater than its total liabilities
The quick ratio has increased by 33% YoY and by 22% from the previous quarter
BRKR's total liabilities is down by 19% YoY
Bruker's debt is 24% less than its equity
BRKR's debt to equity is down by 43% year-on-year but it is up by 12% since the previous quarter
BRKR's equity is up by 32% YoY but it is down by 2.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.